FAXXA 15 MG COM REV CT BL AL PLAS PVDC OPC X 42
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1058309840081 -
GGREM
526121020138604 -
Código de barras
7896004776392
O que a fonte publica
- Detentor do registro
- GERMED FARMACEUTICA LTDA
- Princípios ativos
- RIVAROXABANA
- Embalagem
- 15 MG COM REV CT BL AL PLAS PVDC OPC X 42
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- B1F - INIBIDORES DIRETOS DO FATOR XA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "FAXXA 15 MG COM REV CT BL AL PLAS PVDC OPC X 42",
"holder": "GERMED FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004776392"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526121020138604",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "45.992.062/0001-65",
"priceRegime": "Regulado",
"productName": "FAXXA",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "15 MG COM REV CT BL AL PLAS PVDC OPC X 42",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "364.76",
"icms-12": "414.50",
"icms-17": "439.47",
"icms-18": "444.83",
"icms-19": "450.32",
"icms-20": "455.95",
"icms-21": "461.72",
"icms-22": "467.64",
"icms-23": "473.71",
"icms-17.5": "442.13",
"icms-19.5": "453.12",
"icms-20.5": "458.82",
"icms-22.5": "470.66",
"icms-12-alc": "409.53",
"icms-17-alc": "434.20",
"icms-18-alc": "439.49",
"icms-19-alc": "444.92",
"icms-20-alc": "450.48",
"icms-21-alc": "456.18",
"icms-22-alc": "462.03",
"icms-23-alc": "468.03",
"withoutTaxes": "360.38",
"icms-17.5-alc": "436.83",
"icms-19.5-alc": "447.68",
"icms-20.5-alc": "453.31",
"icms-22.5-alc": "465.01"
},
"pisCofinsList": "Positiva",
"substanceText": "RIVAROXABANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "502.78",
"icms-12": "571.35",
"icms-17": "605.76",
"icms-18": "613.15",
"icms-19": "620.72",
"icms-20": "628.48",
"icms-21": "636.43",
"icms-22": "644.59",
"icms-23": "652.96",
"icms-17.5": "609.43",
"icms-19.5": "624.58",
"icms-20.5": "632.44",
"icms-22.5": "648.76",
"icms-12-alc": "566.15",
"icms-17-alc": "600.26",
"icms-18-alc": "607.57",
"icms-19-alc": "615.08",
"icms-20-alc": "622.76",
"icms-21-alc": "630.64",
"icms-22-alc": "638.73",
"icms-23-alc": "647.02",
"withoutTaxes": "498.21",
"icms-17.5-alc": "603.89",
"icms-19.5-alc": "618.89",
"icms-20.5-alc": "626.67",
"icms-22.5-alc": "642.85"
},
"invalidBarcodes": [],
"activeSubstances": [
"RIVAROXABANA"
],
"therapeuticClass": "B1F - INIBIDORES DIRETOS DO FATOR XA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1058309840081",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "B1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526121020138604"